EuBiologics Co (XKRX:206650) Ending Cash Position : ₩18,258 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is EuBiologics Co Ending Cash Position?

EuBiologics Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ₩18,258 Mil.

EuBiologics Co's quarterly Ending Cash Position increased from Sep. 2024 (₩11,900 Mil) to Dec. 2024 (₩22,854 Mil) but then declined from Dec. 2024 (₩22,854 Mil) to Mar. 2025 (₩18,258 Mil).

EuBiologics Co's annual Ending Cash Position declined from Dec. 2022 (₩11,044 Mil) to Dec. 2023 (₩9,897 Mil) but then increased from Dec. 2023 (₩9,897 Mil) to Dec. 2024 (₩22,854 Mil).

EuBiologics Co Ending Cash Position Historical Data

The historical data trend for EuBiologics Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EuBiologics Co Ending Cash Position Chart

EuBiologics Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

53,088.17

6,534.63

11,044.02

9,897.18

22,854.17

EuBiologics Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															14,463.03	8,992.34	11,899.53	22,854.17	18,258.48

EuBiologics Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

EuBiologics Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	9897.179	+	12956.986
	=	22,854

EuBiologics Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	22854.165	+	-4595.686
	=	18,258

EuBiologics Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of EuBiologics Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

EuBiologics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EuBiologics Co Ltd (XKRX:206650) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

6F Bomnal-A-Chim B/D Mabang-ro 8, Seocho-gu, Seoul, KOR, 06778

Website

http://www.eubiologics.com

EuBiologics Co Ltd is a biopharmaceutical company, which develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine, Inaba Cairo, and among others.

EuBiologics Co Headlines

No Headlines